The conclusion reiterates the problems with analyzing this new constellation of power and of predicting its outcomes. Certain effective provisions are highlighted such as Section 3d of India’s new Patents Act which maintains rigorous standards of inventiveness and efficacy, preventing the “evergreening” of patents and “me too” drugs that have been awarded patents elsewhere. The study ends with a brief comparison to similar patent struggles in Brazil and an assessment of programs that offer more equitable approaches to innovation and ownership such as the Health Impact Fund and the Open Source Drug Discovery program.
Cornell Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us.